Durham, United Kingdom

Antal Harsanyi

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Antal Harsanyi: Innovator in Pharmaceutical Chemistry

Introduction

Antal Harsanyi is a notable inventor based in Durham, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that reflect his innovative approach to drug development.

Latest Patents

Harsanyi's latest patents include a "Process for preparing Fostemsavir," which details a method for the preparation of a compound of Formula IV, wherein P is H or a suitable protecting group. This process involves the preparation of a compound of Formula I, where P is H or a suitable protecting group and R is H or Calkyl. Another significant patent is for a "Process for producing fluorocytosine and fluorocytosine derivatives." This invention relates to a method of manufacturing a fluorocytosine-based compound of Formula I, along with a pharmaceutical drug substance and a method for its manufacture, as well as various therapeutic uses of the compounds and compositions derived from this invention.

Career Highlights

Throughout his career, Harsanyi has worked with prominent organizations, including Viiv Healthcare UK Limited and the University of Durham. His work in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Harsanyi has collaborated with esteemed colleagues such as Andrew David Searle and Graham Sandford, further enhancing the impact of his work in the pharmaceutical field.

Conclusion

Antal Harsanyi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His innovative methods continue to pave the way for advancements in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…